-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia

Dow Jones·06/24/2026 20:15:00

Please log in to view news